Krämer, I., König, L., Luft, T., Hegenbart, U., Schönland, S., Eichkorn, T., . . . Dreger, P. (2025). Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma. Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation, 60(5), 581. https://doi.org/10.1038/s41409-025-02522-4
Chicago-referens (17:e uppl.)Krämer, Isabelle, et al. "Intermediate-dose TBI/fludarabine Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Peripheral T-cell Lymphoma." Bone Marrow Transplantation: Official Journal of the European Society for Blood and Marrow Transplantation 60, no. 5 (2025): 581. https://doi.org/10.1038/s41409-025-02522-4.
MLA-referens (9:e uppl.)Krämer, Isabelle, et al. "Intermediate-dose TBI/fludarabine Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Peripheral T-cell Lymphoma." Bone Marrow Transplantation: Official Journal of the European Society for Blood and Marrow Transplantation, vol. 60, no. 5, 2025, p. 581, https://doi.org/10.1038/s41409-025-02522-4.
